Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone-Metastatic, Castration-Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Not applicableStudy completedNCT03419442
What this trial is testing

Multi-academic Center Study of Xofigo Patients

Who this might be right for
Prostate Cancer, Castration Resistant
Bayer 150
Testing effectiveness (Phase 2)Ended earlyNCT01994590
What this trial is testing

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00286091
What this trial is testing

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Amgen 1,435
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Testing effectiveness (Phase 2)Study completedNCT02346526
What this trial is testing

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone
Massachusetts General Hospital 22
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Not applicableUnknownNCT01168141
What this trial is testing

Window Study of ZD4054 in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastasis
The Christie NHS Foundation Trust 30
Testing effectiveness (Phase 2)Study completedNCT01074138
What this trial is testing

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Bone-Metastatic, Castration-Resistant Prostate Cancer
Athenex, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT02565901
What this trial is testing

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7+1 more
University of Washington 28
Testing effectiveness (Phase 2)WithdrawnNCT07025512
What this trial is testing

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Who this might be right for
Metastatic Castration Resistant Prostate CancerCytopeniaAnemia+1 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00838201
What this trial is testing

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Who this might be right for
CancerCarcinomaCastrate-Resistant Prostate Cancer+2 more
Amgen 384
Early research (Phase 1)Ended earlyNCT02995330
What this trial is testing

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)UnknownNCT03305224
What this trial is testing

The Combination Therapy With Ra-223 and Enzalutamide

Who this might be right for
Castration-resistant Prostate CancerBone Metastases
Taro Iguchi, MD, PHD 10
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Testing effectiveness (Phase 2)Ended earlyNCT04159896
What this trial is testing

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 10
Very early researchStudy completedNCT02204943
What this trial is testing

Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Bone Metastatic Castration-Resistant Prostate Cancer
Duke University 20
Very early researchNot Yet RecruitingNCT07609225
What this trial is testing

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)Study completedNCT02512458
What this trial is testing

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

Who this might be right for
Bone Metastatic Prostate Cancer
Hellenic Cooperative Oncology Group 60
Next Page